Rimmyrah
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Rimmyrah, covering 2026-01-09 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Rimmyrah (ranibizumab) — Qilu Pharma Spain S.L.
3 regulatory and trial events tracked for Rimmyrah, covering 2026-01-09 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Rimmyrah (ranibizumab) — Qilu Pharma Spain S.L.